Want to see SE:ERMA full AI Analyst Report?
Enorama Pharma AB (ERMA) Financial Statements
Enorama Pharma AB Financial Overview
Enorama Pharma AB's market cap is currently $62.65M. The company's EPS TTM is $-0.81; its P/E ratio is -1.04; Enorama Pharma AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.74M | $ 15.77M | $ 1.36M | $ 6.85M | $ 11.04M |
| Gross Profit | $ -61.78M | $ 3.70M | $ -3.90M | $ -616.00K | $ 2.13M |
| Operating Income | $ -62.12M | $ -47.52M | $ -41.84M | $ -41.47M | $ -26.94M |
| EBITDA | $ -61.65M | $ -20.41M | $ -40.18M | $ -37.22M | $ -25.56M |
| Net Income | $ -75.14M | $ -43.81M | $ -44.61M | $ -41.78M | $ -28.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.04M | $ 2.08M | $ 6.15M | $ 4.14M | $ 12.20M |
| Total Assets | $ 8.26M | $ 15.89M | $ 34.38M | $ 48.72M | $ 50.93M |
| Total Debt | $ 0.00 | $ 0.00 | $ 436.00K | $ 1.91M | $ 3.79M |
| Net Debt | $ -3.04M | $ -2.08M | $ -5.72M | $ -2.23M | $ -8.41M |
| Total Liabilities | $ 31.71M | $ 8.09M | $ 14.85M | $ 17.20M | $ 29.58M |
| Stockholders' Equity | $ -23.45M | $ 7.80M | $ 19.54M | $ 31.52M | $ 21.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -59.26M | $ -35.70M | $ -41.35M | $ -32.96M | $ -31.99M |
| Operating Cash Flow | $ -59.26M | $ -35.70M | $ -41.35M | $ -32.96M | $ -30.16M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.82M |
| Financing Cash Flow | $ 50.69M | $ 35.29M | $ 41.86M | $ 25.34M | $ 39.51M |
Currency in SEK
